<DOC>
	<DOCNO>NCT00905424</DOCNO>
	<brief_summary>To evaluate efficacy SPD489 use augmentation antidepressant treatment major depressive disorder ( MDD ) measure mean change total Montgomery-Çºsberg Depression Rating Scale ( MADRS ) score .</brief_summary>
	<brief_title>Exploratory Study SPD489 Adults With Major Depressive Disorder ( MDD ) Augmentation Therapy Antidepressant</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Adults age 1855 primary diagnosis nonpsychotic MDD History nonresponse multiple antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>